The expert video roundtable discussion is a 45-minute interactive case-based panel discussion structured like a TV broadcast featuring expert faculty discussing late-breaking and important clinical issues in the context of case presentations with expert commentary. The panel is composed of three faculty experts, with one serving as the moderator. Interactive Panel Discussions provide expert perspectives and commentary through a roundtable discussion and video, within the context of case presentations. Additionally, the Case-Based Panel Discussion format builds consensus among experts who are familiar with the knowledge, competence, and performance gaps in treating COPD. This format has been selected due to its ability to provide expert interpretation and analysis among recognized authorities in COPD to bring clarity to practicing physicians and health care providers on best practices for improved patient outcomes. Downloadable slides can be included with the activity, and a transcript with slides is also available for online and offline viewing.

Currently, treatments for PD have several limitations. L-DOPA can induce motor complications, whereas dopamine agonists, MAO-B inhibitors, and COMT inhibitors improve motor functions, but tend to worsen dyskinesia. New therapies, including partial dopamine agonists, adenosine 2A antagonists, and new formulations for existing therapies are under investigation. Physicians should be up to date on identifying the most appropriate therapies based on emerging science and disease staging, and should implement patient education into their practice.

This CME Outfitters Live and On Demand features national expert faculty sharing best practices for primary care management of HBV infection within the framework of American Association for the Study of Liver Diseases guidelines, emerging data, and expert experience and thought. This activity is the flagship educational experience in the CME Outfitters vWorld^™ virtual learning environment, which offers online gaming, improved peer interaction, a resource library, and more.

The goal of MS disease management with the early induction of disease-modifying therapies is to intervene prior to irreversible neuronal destruction in order to delay disability progression and improve quality of life. However, the translation of this research to clinical practice has been challenging, with a lag in the early initiation of pharmacotherapeutics that have the potential to slow disease course and improve patient prognosis. The following educational gaps were identified via expert physician interviews, extensive literature research, and information gathered from previous MS programs.

Cease Smoking Today (CS2day) is a nine-partner collaborative designed to reduce the number of persons who smoke and decrease morbidity and mortality from tobacco-related illness. According to the Clinical Practice Guideline: Treating Tobacco Use and Dependence 2008 Update, the 5 A's (ask, advise, assess, assist, arrange) are an effective approach that clinicians should take to identify patients who smoke and to assist these patients with quitting. This online activity is designed to guide clinicians through the evidence-based methods for addressing smoking with patients (via the "5 A's" framework), covering key points and practical tips to overcome common barriers. Downloadable tools are also provided to help clinicians implement the 5 A's in clinical practice.